203 related articles for article (PubMed ID: 28876328)
21. Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue).
Ebbesen F; Madsen PH; Vandborg PK; Jakobsen LH; Trydal T; Vreman HJ
Pediatr Res; 2016 Oct; 80(4):511-5. PubMed ID: 27331354
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
[TBL] [Abstract][Full Text] [Related]
23. Filtered sunlight versus intensive electric powered phototherapy in moderate-to-severe neonatal hyperbilirubinaemia: a randomised controlled non-inferiority trial.
Slusher TM; Vreman HJ; Brearley AM; Vaucher YE; Wong RJ; Stevenson DK; Adeleke OT; Ojo IP; Edowhorhu G; Lund TC; Gbadero DA
Lancet Glob Health; 2018 Oct; 6(10):e1122-e1131. PubMed ID: 30170894
[TBL] [Abstract][Full Text] [Related]
24. Hyperbilirubinemia in Term Newborns Needing Phototherapy within 48 Hours after Birth in a Japanese Birth Center.
Tsujimae S; Yoshii K; Yamana K; Fujioka K; Iijima K; Morioka I
Kobe J Med Sci; 2018 Sep; 64(1):E20-E25. PubMed ID: 30282894
[TBL] [Abstract][Full Text] [Related]
25. Action spectrum of phototherapy in hyperbilirubinemic neonates.
Ebbesen F; Donneborg ML; Vandborg PK; Vreman HJ
Pediatr Res; 2022 Sep; 92(3):816-821. PubMed ID: 34789840
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study.
Kuzniewicz MW; Escobar GJ; Wi S; Liljestrand P; McCulloch C; Newman TB
J Pediatr; 2008 Aug; 153(2):234-40. PubMed ID: 18534217
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized controlled study comparing low-cost LED and conventional phototherapy for treatment of neonatal hyperbilirubinemia.
Viau Colindres J; Rountree C; Destarac MA; Cui Y; Pérez Valdez M; Herrera Castellanos M; Mirabal Y; Spiegel G; Richards-Kortum R; Oden M
J Trop Pediatr; 2012 Jun; 58(3):178-83. PubMed ID: 21914717
[TBL] [Abstract][Full Text] [Related]
28. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy.
Chang PW; Kuzniewicz MW; McCulloch CE; Newman TB
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196932
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of new microprocessed phototherapy system with five high intensity light emitting diodes (Super LED).
Martins BM; de Carvalho M; Moreira ME; Lopes JM
J Pediatr (Rio J); 2007; 83(3):253-8. PubMed ID: 17551656
[TBL] [Abstract][Full Text] [Related]
30. High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia.
de Carvalho M; Mochdece CC; Sá CA; Moreira ME
Acta Paediatr; 2011 Apr; 100(4):620-3. PubMed ID: 21251060
[TBL] [Abstract][Full Text] [Related]
31. Which phototherapy system is most effective in lowering serum bilirubin in very preterm infants?
Romagnoli C; Zecca E; Papacci P; Vento G; Girlando P; Latella C
Fetal Diagn Ther; 2006; 21(2):204-9. PubMed ID: 16491004
[TBL] [Abstract][Full Text] [Related]
32. Broad-spectrum light versus blue light for phototherapy in neonatal hyperbilirubinemia: a randomized controlled trial.
Pratesi S; Di Fabio S; Bresci C; Di Natale C; Bar S; Dani C
Am J Perinatol; 2015 Jul; 32(8):779-84. PubMed ID: 25545446
[TBL] [Abstract][Full Text] [Related]
33. Unconjugated free bilirubin in preterm infants.
van der Schoor LW; Dijk PH; Verkade HJ; Kamsma AC; Schreuder AB; Groen H; Hulzebos CV
Early Hum Dev; 2017; 106-107():25-32. PubMed ID: 28183002
[TBL] [Abstract][Full Text] [Related]
34. Effect of infants' position on serum bilirubin level during conventional phototherapy.
Donneborg ML; Knudsen KB; Ebbesen F
Acta Paediatr; 2010 Aug; 99(8):1131-4. PubMed ID: 20528799
[TBL] [Abstract][Full Text] [Related]
35. The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrial.
Hulzebos CV; Dijk PH; van Imhoff DE; Bos AF; Lopriore E; Offringa M; Ruiter SA; van Braeckel KN; Krabbe PF; Quik EH; van Toledo-Eppinga L; Nuytemans DH; van Wassenaer-Leemhuis AG; Benders MJ; Korbeeck-van Hof KK; van Lingen RA; Groot Jebbink LJ; Liem D; Mansvelt P; Buijs J; Govaert P; van Vliet I; Mulder TL; Wolfs C; Fetter WP; Laarman C;
PLoS One; 2014; 9(6):e99466. PubMed ID: 24927259
[TBL] [Abstract][Full Text] [Related]
36. Moderate unconjugated hyperbilirubinemia causes a transient but delayed suppression of amplitude-integrated electroencephalographic activity in preterm infants.
Ter Horst HJ; Bos AF; Duijvendijk J; Hulzebos CV
Neonatology; 2012; 102(2):120-5. PubMed ID: 22699267
[TBL] [Abstract][Full Text] [Related]
37. Effect of universal neonatal transcutaneous bilirubin screening on blood draws for bilirubin analysis and phototherapy usage.
Wickremasinghe AC; Karon BS; Saenger AK; Cook WJ
J Perinatol; 2012 Nov; 32(11):851-5. PubMed ID: 22343396
[TBL] [Abstract][Full Text] [Related]
38. The use of intensive phototherapy in severe neonatal hyperbilirubinemia.
Abd-Ellatif MA; Abd-Ellatif DA
J Egypt Soc Parasitol; 2012 Aug; 42(2):483-94. PubMed ID: 23214225
[TBL] [Abstract][Full Text] [Related]
39. A Randomized Trial Comparing NeoLight Skylife and Blanket Phototherapy in Newborn Indirect Hyperbilirubinemia.
Abrams M; Gosselin K; Roth CK; Hoffman N
Clin Pediatr (Phila); 2024 Jun; 63(6):774-778. PubMed ID: 37522330
[TBL] [Abstract][Full Text] [Related]
40. Standardization of phototherapy for neonatal hyperbilirubinemia using multiple-wavelength irradiance integration.
Kato S; Iwata O; Yamada Y; Kakita H; Yamada T; Nakashima H; Sugiura T; Suzuki S; Togari H
Pediatr Neonatol; 2020 Feb; 61(1):100-105. PubMed ID: 31473126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
